- Neuralink, the neurotechnology company co-founded by Tesla (NASDAQ:TSLA) CEO Elon Musk, said on Thursday it will launch a clinical study in Great Britain to test how its chips can help patients with severe paralysis to control digital and physical tools
Elon Musk’s Neuralink to test brain chips in the UK

Related
Boeing sued by Alaska Airlines flight attendants over mid-ai...
23 minutes ago
0
Liberty Global signals strategic asset separation within 12–...
33 minutes ago
0
Silvercrest signals robust $200M actionable pipeline while e...
49 minutes ago
0
Cboe raises 2025 organic net revenue growth guidance to high...
57 minutes ago
0
Ichor Holdings Q2 2025 Earnings Preview
59 minutes ago
0
Ryman Hospitality Properties Q2 2025 Earnings Preview
59 minutes ago
0
FreightCar America Q2 2025 Earnings Preview
59 minutes ago
0
Syndax Pharmaceuticals Q2 2025 Earnings Preview
59 minutes ago
0
Inspire Medical Systems Q2 2025 Earnings Preview
59 minutes ago
0
Scienture files $200M mixed securities shelf
1 hour ago
0
DIH receives deficiency letter from Nasdaq
1 hour ago
0
Trending
Popular
صدور هشدار زرد هواشناسی در چهارمحال و بختیاری
3 days ago
3
تصویری پربازدید از مجسمه پاندای کونگفو کار
3 days ago
2
© FBT Company 2025. All rights are reserved